An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: A Collaborative Ependymoma Research Network study (CERN) Meeting Abstract
| Authors: | DeWire, M.; Fouladi, M.; Stewart, C.; Wetmore, C.; Hawkins, C.; Jacobs, C.; Yuan, Y.; Goldman, S.; Fisher, P.; Rytting, M.; Bouffet, E.; Khakoo, Y.; Hwang, E.; Foreman, N.; Gilbert, M.; Gilbertson, R.; Gajjar, A. |
| Abstract Title: | An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: A Collaborative Ependymoma Research Network study (CERN) |
| Meeting Title: | 2nd Annual Pediatric Neuro-Oncology Basic and Translational Research Conference |
| Journal Title: | Neuro-Oncology |
| Volume: | 15 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2013 May 16-17 |
| Meeting Location: | Fort Lauderdale, FL |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2013-04-01 |
| Start Page: | 47 |
| Language: | English |
| ACCESSION: | WOS:000318570500171 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/not047 |
| PMCID: | PMC3635504 |
| Notes: | Meeting Abstract: 0177 -- "Source: Wos" |
